Skip to main content
. 2016 Jul 6;34(4):191–198. doi: 10.1111/1755-5922.12183

Figure 1.

Figure 1

Study design. *No patients participated in the titration period 1. ABPM, ambulatory blood pressure monitoring; ACE, angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; bid, twice daily; HF, heart failure; PD, pharmacodynamics; PK, pharmacokinetics.